PAACT Inc
Free Prostate Cancer Newsletter Signup
  • Home
  • DONATIONS
  • NEWSLETTER
  • BLOG
  • GALLERY
  • ABOUT US
    • President & CEO
    • Our Team
    • Founder
    • Mission & Vision
    • Achievements / Milestones & Awards
    • Board of Directors
    • Honorary Board Members
    • Medical Advisory Board
    • Contributing Vendors
  • CONTACT US
Home » Archives for Casodex
image_print

Clarifying Concepts – Every Drug has 2 Names, Jan Manarite, 2015

December 3, 2015 by Paactusa

Every Drug has 2 names.  From antibiotics to chemotherapy, every drug has a brand name and a generic name. For the patient, this can be confusing, especially when trying to research a treatment, which is essential in developing better questions, and essential in Shared-Decision Making with … [Read more...]

Filed Under: Screening & Prevention, Newly Diagnosed & Active Surveillance, PSA Rising (After Surgery, Radiation, or Other Local Therapy), PSA Rising (On Hormone Therapy), PSA Stable (After Surgery, Radiation, or Other Local Therapy), PSA Stable (On Hormone Therapy) Tagged With: Xtandi, radium, Xofigo, abiraterone, avodart, bicalutamide, cabazitaxel, Casodex, Cipro, degarelix, denosumab, docetaxel, dutasteride, Eligard, enzalutamide, Eulexin, finasteride, Firmagon, Flomax, flutamide, goserlin, Hytrin, Jalyn, Jevtana, ketoconazole, leuprolide, Levaquin, Nilandron, nilutamide, Nizoral, Prolia, proscar, Provenge, Rapaflo, sipuleucel-T, tamsulosin, Taxotere, terazosin, Trelstar, triptorelin, Xgeva, Zoladex, Zometa, Zytiga

20+ YEAR SURVIVORS, 2013

December 3, 2015 by Paactusa

Letters from Six PC Patients - Fall 2013 Newsletter (FOR PATIENT CONTACT INFORMATION, PLEASE CALL PAACT AT 616-453-1477) You asked for input from prostate cancer survivors of twenty years. My experience may be of interest and could convince others that “cancer” is just a word - not a sentence. In … [Read more...]

Filed Under: Newly Diagnosed & Active Surveillance, PSA Rising (After Surgery, Radiation, or Other Local Therapy), PSA Rising (On Hormone Therapy), Caregivers Tagged With: Incontinence, brachytherapy, Casodex, prostatectomy, surgery, Cryo, Lupron, suriviors, survival, tomotherapy, radiation, Lloy Ney, C11 Acetate, erectily dysfunction, Gleason

Recent Posts

  • PSA Screening – Where are we now?
  • My Prostate Cancer Story: Avid Reader Becomes Advocate
  • New PET Scan Approved for Prostate Cancer – for PSA Recurrence After Treatment
  • Focal Therapy – Brief Overview and Focal Cryo Experience at PIOA
  • Some Current Trials – In the Field of Biomarkers
  • On the Horizon-Individualized Biomarker Driven Therapy for CRPC
  • Adding Prednisone to Zytiga – More Side Effects?
  • AR-V7 Blood Test now Available – for mCRPC Patients
  • Dr Fred Lee, 1930 – 2016
  • Winter 2015, Article 71

Tags

abiraterone AR-V7 bone scan cholesterol clinical trials CRPC Cryo D3 diet ED exercise Focal therapy heart healthy imaging Incontinence jan manarite manarite mCRPC metastases MRI nerve sparing newly diagnosed Nuclear medicine paact paactusa PET scan Prevention Prostate Cancer prostatectomy prostate healthy Provenge PSA PSA Screening Radiologist screening side effects sleep surgery testosterone Tewari U.S. Preventive Services Task Force vitamin D Xofigo Xtandi Zytiga
Donations | Newsletter | Events | Resources | About Us | Gallery | Blog | Contact Us | Our Team | Privacy
Copyright PAACT Inc. 2018, All Rights Reserved.
  •  
  •  
"Bayer is a Supporting Sponsor For Educational Content of This Website"